Astera Labs (NASDAQ:ALAB) General Counsel Philip Mazzara Sells 14,076 Shares

Astera Labs, Inc. (NASDAQ:ALAB) General Counsel Philip Mazzara sold 14,076 shares of the company’s stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of $231.78, for a total value of $3,262,535.28. Following the completion of the transaction, the general counsel owned 104,139 shares in the company, valued at $24,137,337.42. This represents a 11.91% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Philip Mazzara also recently made the following trade(s):

• On Wednesday, April 1st, Philip Mazzara sold 10,000 shares of Astera Labs stock. The shares were sold at an average price of $107.77, for a total value of $1,077,700.00.
• On Monday, March 2nd, Philip Mazzara sold 10,000 shares of Astera Labs stock. The shares were sold at an average price of $117.47, for a total value of $1,174,700.00.

Astera Labs Stock Performance

ALAB opened at $287.48 on Thursday. Astera Labs, Inc. has a one year low of $84.78 and a one year high of $287.70. The stock has a market capitalization of $49.28 billion, a PE ratio of 194.24, a P/E/G ratio of 3.23 and a beta of 3.35. The business’s 50 day moving average price is $163.12 and its 200 day moving average price is $157.97.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. The firm had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm’s quarterly revenue was up 93.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, equities research analysts forecast that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera Labs’ recent investor presentation and conference remarks highlighted new networking and switching products, reinforcing the company’s positioning as an AI infrastructure beneficiary.
• Positive Sentiment: Wall Street commentary has turned more constructive, with reports of analyst “buy” recommendations helping extend the rally in ALAB shares.
• Positive Sentiment: Traders also flagged bullish order-flow and options activity, including a “Power Inflow” signal and elevated call option volume, which can add momentum to a fast-rising stock.

Hedge Funds Weigh In On Astera Labs

Several large investors have recently bought and sold shares of ALAB. Nordea Investment Management AB purchased a new position in Astera Labs in the fourth quarter valued at about $2,028,000. Geneva Partners LLC purchased a new position in shares of Astera Labs during the 3rd quarter worth approximately $1,876,000. Numerai GP LLC increased its stake in shares of Astera Labs by 153.1% during the 3rd quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock worth $2,587,000 after purchasing an additional 7,992 shares in the last quarter. Handelsbanken Fonder AB increased its stake in shares of Astera Labs by 289.5% during the 3rd quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company’s stock worth $24,710,000 after purchasing an additional 93,800 shares in the last quarter. Finally, Paragon Advisors LLC purchased a new position in shares of Astera Labs during the 3rd quarter worth approximately $1,829,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on ALAB. Loop Capital began coverage on Astera Labs in a research report on Thursday, March 5th. They issued a “buy” rating and a $250.00 target price on the stock. Morgan Stanley upped their price objective on Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. TD Cowen upped their price objective on Astera Labs from $140.00 to $225.00 and gave the stock a “hold” rating in a research report on Wednesday, May 6th. UBS Group began coverage on Astera Labs in a report on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 target price on the stock. Finally, Jefferies Financial Group restated a “buy” rating and issued a $270.00 price objective on shares of Astera Labs in a research note on Wednesday, May 6th. Fifteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $233.75.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.